Bristol Myers joins in vivo CAR-T race with $1.5B Orbital acquisitionnews2025-10-10T11:28:23+00:00October 10th, 2025|Endpoints News|
Altos Labs is testing anti-aging therapies in organs kept alive outside the bodynews2025-10-09T19:55:46+00:00October 9th, 2025|Endpoints News|
Mammoth Biosciences plans first trial of triglyceride-lowering gene editing therapynews2025-10-09T13:30:56+00:00October 9th, 2025|Endpoints News|
Finnish researchers report success in mid-stage study of heart disease gene therapynews2025-10-09T10:33:04+00:00October 9th, 2025|Endpoints News|
ARPA-H awards several biotechs funding to make in vivo therapiesnews2025-10-08T19:15:18+00:00October 8th, 2025|Endpoints News|
Q&A: Scientists behind Baby KJ’s custom CRISPR drug are planning to help more children news2025-10-08T18:29:20+00:00October 8th, 2025|Endpoints News|
Lexeo eyes faster path to approval for Friedreich’s ataxia gene therapynews2025-10-07T14:45:24+00:00October 7th, 2025|Endpoints News|
Cell therapy CDMO Mytos unveils its first facility in the UK news2025-10-06T12:00:45+00:00October 6th, 2025|Endpoints News|
Arbor partners with Chiesi Group in gene editing dealnews2025-10-06T11:00:11+00:00October 6th, 2025|Endpoints News|
Gene therapy startup launches with $11M to tackle aging disease of the eyenews2025-10-02T11:00:20+00:00October 2nd, 2025|Endpoints News|
